---
title: "Lidolog Kit, Kit Contains: Lidocaine HCl Injection, USP, 2% (2mL) vial, 1 Dos... — FDA record D-0713-2026 | Is It on Recall"
description: "Labeling: Not Elsewhere Classified: The label wrap covers the barcode, making it hard to scan"
url: https://isitonrecall.com/recall/fda-drug-d-0713-2026-lidolog-kit-kit-contains-lidocaine-hcl-injection-usp-2-2ml-vial-1-dose-single-use-only-rx-only-distr/
updated: 2026-10-01
site: "Is It on Recall"
language: en
---

[Recall archive](https://isitonrecall.com/archives/) / FDA drug enforcement

# Lidolog Kit, Kit Contains: Lidocaine HCl Injection, USP, 2% (2mL) vial, 1 Dose, Single use Only, Rx Only, Distributed... — FDA record D-0713-2026

Reported ongoing

Status as reported in the agency record. FDA warns that enforcement status may not track the current recall lifecycle; check the current official notice.

Source date Jul 15, 2026. Retrieved Oct 1, 2026. Last updated Oct 1, 2026.

Archive changed Oct 1, 2026. USDA FSIS records are unavailable; [check FSIS directly](https://www.fsis.usda.gov/recalls). [Source coverage and dates](https://isitonrecall.com/sources/).

## What the record says

- **Product**: Lidolog Kit, Kit Contains: Lidocaine HCl Injection, USP, 2% (2mL) vial, 1 Dose, Single use Only, Rx Only, Distributed by: Enovachem Pharmaceuticals, Torrance, CA 90501, NDC: 76420-760-01.
- **Reason**: Labeling: Not Elsewhere Classified: The label wrap covers the barcode, making it hard to scan
- **Classification**: Class III
- **Recalling firm**: Asclemed USA Inc.
- **Quantity**: 18 kits
- **Agency-reported status**: Ongoing
- **Source record identifier**: D-0713-2026

[Open the official record](https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-0713-2026%22)

[What the recall classes mean](https://isitonrecall.com/guides/recall-classes/). Classification is an agency assessment, not individual medical advice.

## Lot and product identifiers

| Label field | Details supplied by the agency |
| --- | --- |
| Lot, code or applicability | Lot: 070126X1, Exp. 12/31/2027. |

Match all identifying details in the current notice. A brand name alone is not enough.

## Distribution

Within U.S. - Tennessee

States below are derived from the distribution text, including nationwide wording. They are not inferred from the firm's address.

- [Tennessee](https://isitonrecall.com/state/tennessee/)

## Dates in the source

- **Report date**: Jul 29, 2026
- **Recall initiation date**: Jul 15, 2026
- **Center classification date**: Jul 20, 2026

FDA company pages use the listing date; enforcement records use initiation dates; CPSC uses recall date; NHTSA uses report-received date. These dates are not interchangeable.

## What to do next

Read the official notice for the action that applies to your exact product.

[Read the current instructions](https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-0713-2026%22)

## Before changing a medicine

Follow urgent instructions in the current official recall notice. Speak to your pharmacist or prescriber before stopping or changing a prescribed medicine.

Talk to your doctor or pharmacist if you have questions or concerns about your medicine. [FDA medication recall guidance](https://www.fda.gov/drugs/drug-recalls/understanding-drug-recalls-what-know-and-what-do)

## Related records

[Medications records](https://isitonrecall.com/category/medications/) [Asclemed USA Inc. records](https://isitonrecall.com/brand/asclemed-usa-inc/)